Benitec Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 2, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Cap	454	307	71	7	9	35
Market Cap Growth	12.05%	335.63%	938.90%	-28.41%	-72.71%	296.13%
Enterprise Value	270.28	210.24	19.92	4.87	6.23	15.17
Last Close Price	13.22	11.70	6.99	4.06	19.72	72.25
PS Ratio	-	-	-	90.48	129.85	588.64
PB Ratio	2.48	3.16	1.49	33.60	3.29	1.74
P/TBV Ratio	3.21	4.35	2.72	27.85	3.29	0.91
EV/Sales Ratio	-	-	-	64.91	85.32	257.18
Debt / Equity Ratio	0.00	0.01	0	1.41	0.19	0
Net Debt / Equity Ratio	-1.00	-1.00	-1.07	-9.49	-1.13	-0.98
Net Debt / EBITDA Ratio	3.44	2.34	2.28	0.10	0.19	1.49
Net Debt / FCF Ratio	9.28	4.11	2.58	0.11	0.20	1.50
Asset Turnover	-	0	0	0.01	0.01	0.00
Quick Ratio	56.43	54.26	10.38	0.64	1.61	14.46
Current Ratio	56.82	54.67	10.49	0.94	1.90	15.05
Return on Equity (ROE)	-26.37%	-52.46%	-91.68%	-1268.61%	-159.08%	-91.79%
Return on Assets (ROA)	-28.56%	-55.03%	-79.37%	-365.64%	-130.55%	-82.48%
Return on Invested Capital (ROIC)	-56.04%	-3715.75%	-2457.92%	-1580.21%	-1494.68%	-1391.61%
Return on Capital Employed (ROCE)	-28.89%	-57.58%	-94.16%	-971.79%	-152.27%	-89.27%
Buyback Yield / Dilution	-37.41%	-97.17%	-1225.16%	-188.30%	-90.24%	-320.63%
Total Shareholder Return	-37.41%	-97.17%	-1225.16%	-188.30%	-90.24%	-320.63%

SEC Filings: 10-K · 10-Q